Related Experiment Videos
Characterization of anti-inflammatory compounds using transcriptomics, proteomics, and metabolomics in combination
Kitty C M Verhoeckx1, Sabina Bijlsma, Sonja Jespersen
1TNO Pharma, Utrechtseweg 48, PO Box 360, 3700AJ Zeist, The Netherlands. Verhoeckx@pharma.tno.nl
International Immunopharmacology
|September 8, 2004
Summary
This study introduces a holistic approach to characterize anti-inflammatory drugs by analyzing their effects on gene, protein, and lipid expression. Distinct molecular patterns can classify known drugs and identify novel anti-inflammatory compounds.
Area of Science:
- Pharmacology
- Systems Biology
- Drug Discovery
Background:
- Discovering novel anti-inflammatory drugs often relies on specific molecular targets, yet broader pathway interactions are crucial.
- Existing anti-inflammatory drugs are classified by their mechanisms of action.
- Characterizing novel compounds requires comprehensive analysis beyond single targets.
Purpose of the Study:
- To investigate a holistic method for characterizing novel anti-inflammatory compounds.
- To utilize multi-omics analysis (transcriptome, proteome, metabolome) for drug classification.
- To identify distinct molecular signatures for different classes of anti-inflammatory agents.
Main Methods:
- Macrophage-like U937 cells were stimulated with lipopolysaccharide (LPS) in the presence or absence of anti-inflammatory compounds.
- Microarrays, 2-D gel electrophoresis, and liquid chromatography-mass spectrometry (LC-MS) were employed to analyze cellular responses.
- In-house developed pattern recognition tools were used for expression pattern analysis.
Main Results:
- Different classes of anti-inflammatory compounds exhibited distinct mRNA, protein, and lipid expression patterns.
- These characteristic patterns can be used to categorize known drugs and identify new ones.
- The study successfully classified several beta (2)-adrenergic agonists (beta2-agonists), including zilpaterol, clenbuterol, and salbutamol, based on their molecular profiles.
- Specific molecular markers (mRNA, protein, lipid) for the investigated anti-inflammatory compounds were identified.
Conclusions:
- A holistic, multi-omics approach provides a powerful method for characterizing and classifying anti-inflammatory compounds.
- This strategy aids in the discovery and classification of novel anti-inflammatory drug leads.
- Distinct molecular signatures can reveal the anti-inflammatory properties of drugs, even those with primary targets in other pathways, such as beta2-agonists.